The global pediatric nebulizer mask market was valued at USD 1.02 Billion in 2021, and it is estimated to reach USD 1.93 Billion in 2028 with a CAGR of 7.4% during the forecast period of 2022-2028. According to the World Health Organization, in 2019, pneumonia killed about 740 180 children under the age of 5 years, accounting for about 14% of all deaths in children under that age group with the growing incidences of respiratory diseases, such as asthma, lung cancer and pneumonia, among children. Along with this, extreme environmental pollution in urban cities and a rise in secondhand smoke disclosure worldwide are expected to drive the demand for pediatric nebulizer masks soon. Furthermore, increasing demand for home healthcare devices and the escalating advancement of respiratory care devices for home use by many healthcare companies are established to offer ample growth opportunities to the market in the upcoming years.
Pediatric Nebulizer Masks are designed to accompany pediatric nebulizers. Kids’ nebulizer masks make handling treatment more relaxed by allowing the child to breathe in and out naturally and allowing the medication to enter through the mouth or the nose. In turn, it helps medication enter the lungs and treat symptoms more quickly. Getting a nebulizer mask for a child means that it is sized appropriately with fun decorative designs that make treatment more playful and encourage your child’s imagination. There are options for infants who arrive in a pacifier nebulizer to promote treatment, even for newborns.
Asthma, Chronic Obstructive Pulmonary Disorder, and other respiratory diseases exert a huge economic burden on healthcare methods of different countries globally. There has been a rise in the majority of these conditions, owing to different factors, including an upsurge in the smoking population, bad air quality, etc. According to the National Strategy for Diagnosis, Management and Prevention of COPD information, the European Union disburses around 6%of its total healthcare budget on controlling respiratory disorders (direct costs) each year. Also, according to the information, COPD accounts for around 60% of the total expenditure on respiratory diseases by the EU each year.
Market players’ developing innovations and investments in developing technologically progressive devices have played a considerable role in improved accessibility to kids and adults, healthcare providers, and other end users. For example, Omron Healthcare, Inc. offers OMRON MicroAIR U100, a battery-operated portable nebulizer with a mask for treating respiratory conditions from a simple cough to asthma. The Micro AIR U100 has a 360-degree operation which allows its usage in any position and makes it completely comfortable for smaller children. Moreover, the device uses unique mesh technology to effectively deliver the medication to the lungs.
It is a grown market, and it is possible to face competition with small children increasing acceptance of alternate devices for treating respiratory diseases. Healthcare providers are increasingly important towards inhalers, including metered-dose inhalers for asthma treatment. MDIs’ clinical and operational benefits in treating asthma and the lower cost of these devices have witnessed a growing shift of young & children patients from nebulization devices to inhalers. Moreover, limited reimbursement procedures in developing economies and increased mesh prices will likely hamper the market during the forecast period.
Before the covid-19 outbreak, elements include increasing geriatric population base; increasing attention about progressive treatment methods for respiratory diseases; improving healthcare infrastructure & skills in developing countries; government endeavors desired at decreasing morbidity rates induced by respiratory infections; increasing disposable income levels; rapid technological advancements in medical equipment industry to decrease hospitalization time for small children suffering from crucial cases concerning respiratory problems.
During the covid-19 period, the pandemic has accelerated the demand for devices to prevent the spread of this respiratory infection efficiently. As the coronavirus cases accelerate, many nations face a crucial shortage of ventilators and meter dose inhalers. However, problems are raised on the safety profile of respiratory devices for transmission of the infection in children. According to the latest report by the Asthma and Allergy Foundation of America, when operated on patients with covid-19 in hospitals, these devices are likely to raise the risk of transmission among patients as healthcare professionals. However, many pharmaceutical companies are developing useful therapies to treat the covid-19 infections, chiefly administered via a nebulizer.
After the covid-19 outbreak, many companies started new technologies to treat respiratory infections in children and young people. In December 2020, Ampio Pharmaceuticals Inc declared opening enrollment for its AP-014 Phase I inhaled Ampion clinical examination in covid-19 patients (young and children). The Ampion in the clinical test is administered utilizing a handheld nebulizer to deliver the drug directly into the lungs. The clinical study’s favorable reactions are expected to drive market growth. Moreover, suppose medical device organizations strongly emphasize the development of advanced devices in this segment that reduce the generation of aerosols. In that case, there is a more substantial possibility of an increase in the growth of this market.
Based on type segmental analysis, the market is segmented into Pneumatic Nebulizer, Ultrasonic nebulizer and Mesh Nebulizer. Pneumatic nebulizers are further classified into breath-actuated and vented nebulizers. Again, mesh nebulizers diverge into static and vibrating type nebulizers. Pneumatic nebulizers monopolize the market due to their convenient handling for children’s efficient design and low cost. Breath actuated nebulizers produce the drug effectively and are expected to grow at the highest CAGR during the forecast period.
The market is segmented into Portable and Table Top based on portability segment analysis. Portable Segment to Notice Significant Growth in Demand during Forecast Period. Table-top devices dominate the market. This segment is anticipated to account for the largest nebulizer mask market share during the forecast period. Prominent factors donating to the higher share of the segment contain an increase in the usage of table-top due to operational advantages presented by these devices and the existence of a large number of participants with a strong table-top nebulizer & mask portfolio.
Based on End-User segmental analysis, the market is segmented into Hospitals, Clinics and Homecare. The hospital’s segment monopolized the global market in 2021. Increased demand for these devices from hospital settings, especially driven by the higher number of children and infant patients admissions with comorbidities, has been pivotal in higher demand for table-top and portable devices globally.
Based on the regional segment, the market is segmented into North America, Europe, Asia-Pacific, South America and The Middle East & Africa. The market in the Asia-Pacific is calculated to notice considerable growth over the forecast period on the back of the growing majority of chronic respiratory diseases among the pediatric population and the increase in the number of companies producing inhaled drug devices. Moreover, the market in North America is anticipated to hold the largest share during the forecast period explaining the constant inventions in technology in the medical sector.
The companies include Omron Corporation, VYAIRE MEDICAL, Inc. GF Health Products, Rossmax International Ltd., DeVilbiss Healthcare LLC, Allied Healthcare Products, Inc., Teleflex Medical, Inc., Trudell Medical International, DrTrust, B. Well, Swiss AG and global pediatric nebulizer mask market.
Key Stakeholders
| Report Attribute | Details |
|---|---|
| Market Size Value in 2021 | USD 1.02 Billion |
| The revenue forecast in 2028 | USD 1.93 Billion |
| Growth Rate | CAGR of 7.4 % from 2022 to 2028. |
| Historical data | 2017 – 2020 |
| Forecast period | 2022 – 2028 |
| Region covered | North America, Europe, Asia-Pacific, South America, and Middle East & Africa |
| Key companies Profiled | The Companies include Omron Corporation, VYAIRE MEDICAL, Inc. GF Health Products, Rossmax International Ltd., DeVilbiss Healthcare LLC, Allied Healthcare Products, Inc., Teleflex Medical, Inc., Trudell Medical International, DrTrust, B. Well, Swiss AG are the key players. |
By Type
By Portability
By End-User
By Region
The availability of alternative treatment options is estimated to hinder the growth of the pediatric nebulizer mask market.
The companies include Omron Corporation, VYAIRE MEDICAL, Inc. GF Health Products, Rossmax International Ltd., DeVilbiss Healthcare LLC, Allied Healthcare Products, Inc., Teleflex Medical, Inc., Trudell Medical International, DrTrust, B. Well, Swiss AG and global pediatric nebulizer mask market.
The function of a nebulizer is to quickly give your lungs medication, something that an inhaler may not be capable of doing as well. Nebulizers perform with your natural breathing, so they may be perfect for people who have problems operating inhalers, such as babies and small children. A nebulizer treatment may help reduce inflammation in the lungs and open airways, especially in the case of respiratory illnesses like asthma. Young children and babies with other respiratory diseases like COPD who have lung-related difficulties from a cold or flu may help. Once the medicine performs its way into the lungs, you may see comfort from symptoms such as shortness of breath, running nose, wheezing, chest tightness and coughing.
The pneumatic nebulizer segment will hold the largest share in the pediatric nebulizer market.
The Asia-Pacific region will provide more opportunities in the global pediatric nebulizer market due to the growing prevalence of chronic respiratory disease and healthcare expenditure.
Analyst support
After evaluating your requirements and addressing your technical problems, the expert analyst will resolve your query directly.
Customer satisfaction
According to your needs, our expert team will assist you with the capabilities, services, and proper research needs to be required and customize the report accordingly.
Inimitable expertise
Our expert team will create unrivaled reviews to provide you with a deep understanding of the reports.
Assured quality
We have created a systematic way to determine standards and satisfy your expectations.
Instant delivery
Unlike others, we provide you a great deal of instant delivery in the form of PDF/PPT/Word Doc directly to your email address within 24 hours after receiving full payment.
Privacy policy
We understand the inkling of your privacy, we will never misuse your email address.
Custom research service
We are giving you an opportunity through which you can directly ask our expert analyst to customize an exclusive study of the report to serve your research needs.
Quality & accuracy
We provide you with the accurate quality of the customized study of an exclusive report according to your research need.
Data visualization
As the business world’s growing faster every day, we understand the value of data management. We will create the reports by keeping all the visual data sets and metrics in the charts.
Information security
We truly respect your privacy and promise to keep your personal and confidential information safe and secure.